Alkermes (ALKS) Construction in Progress (2020 - 2024)
Alkermes' (ALKS) quarterly Construction in Progress came in at $30.6 million in Q4 2024, up 955.17% year-on-year from $2.9 million in Q1 2024, and up 955.17% on a QoQ basis from $2.9 million in Q4 2023.
Alkermes (ALKS) Construction in Progress (2020 - 2024) Analysis & Trends
Alkermes (ALKS) has 4 years of Construction in Progress data on file, last reported at $30.6 million in Q4 2024.
- On a quarterly basis, Construction in Progress rose 955.17% year-over-year to $30.6 million in Q4 2024; TTM through Dec 2024 was $30.6 million, a 955.17% increase from a year earlier, with the FY2024 full-year figure at $30.6 million, up 955.17% from the prior year.
- Construction in Progress for Q4 2024 stood at $30.6 million, up from $2.9 million in the prior quarter.
- Over the last five years, Construction in Progress for ALKS reached as high as $30.6 million in Q4 2024 and fell as low as $2.9 million in Q4 2023.
- Historically, Construction in Progress has averaged $16.6 million across 4 years, with a median of $16.4 million in 2020.
- On a YoY basis, Construction in Progress climbed as much as 955.17% in 2024 and fell as far as 955.17% in 2024.
- Year by year, Construction in Progress stood at $24.2 million in 2020, then plunged by 64.05% to $8.7 million in 2022, then slumped by 66.67% to $2.9 million in 2023, then surged by 955.17% to $30.6 million in 2024.
- Per Business Quant data, the three most recent Construction in Progress figures were $30.6 million in Q4 2024, $2.9 million in Q4 2023, and $8.7 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.60 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2022 | 8.70 Mn |
| Dec 31, 2020 | 24.20 Mn |